Members of the Board of Directors (GRI 2-9, 2-11)
![graphic](https://nswow-imageresizer.azurewebsites.net/remote/report.galenica.com/ar23/app/uploads/aa929076-d1c7-41c9-ab2d-d6ef3164e304.jpeg?width=1500)
Board member since 2019, born in 1958, Swiss citizen
Corporate Governance:
Independent member
Career highlights: Dr Markus R. Neuhaus held various roles at PwC from 1985 on, including CEO of PwC Switzerland from 2003 to 2012, member of PwC’s Global Board from 2005 to 2007, member of the PwC Network Executive Team from 2010 to 2013, member of PwC’s Office of the Global Chairman from 2013 to 2016, and Chairman of PwC Switzerland from 2012 to 2019.
Qualification: Master of law and doctorate in law from the University of Zurich. Certified tax expert. Various management courses at international business schools (Harvard, Insead, IMD).
Other main activities: Dr Markus R. Neuhaus is a member of the Board of Directors of Barry Callebaut AG and a member of the Board of Directors of Baloise Holding AG and Jacobs Holding AG. He also serves as Vice-Chair of the Board of Trustees of Avenir Suisse.
![graphic](https://nswow-imageresizer.azurewebsites.net/remote/report.galenica.com/ar23/app/uploads/170a1949-eadb-4c04-947c-2db2b6ba62da.jpeg?width=1500)
Board member since 2020, born in 1977, Swiss citizen
Corporate Governance:
Independent member
Career highlights: Pascale Bruderer was a member of the National council from 2002 to 2011 (president of the National council 2009/2010) and a Member of the Council of States from 2011 to 2019. She was formerly a member of the Social Security and Health Committee. She served as president of the umbrella organisation for disabled people, Inclusion Handicap, and was the managing director of Krebsliga Aargau.
Qualification: Master’s degree in political science from the University of Zurich and education at Harvard University (USA) and at the Executive School of the University of St. Gallen.
Other main activities: Pascale Bruderer is a member of the Board of Directors of the TX Group AG. Since 2019, she has been a member of the Board of Crossiety AG and since 2022, Chairwoman of the Board of Directors of Swiss Stablecoin AG.
![graphic](https://nswow-imageresizer.azurewebsites.net/remote/report.galenica.com/ar23/app/uploads/6292fe24-6103-4291-a6a3-5e98ed208329.jpeg?width=1500)
Board member since 2018, born in 1965, Swiss citizen
Corporate Governance:
Independent member
Career highlights: From 2006 to 2017, he held the position of CEO of the Swiss department store group Manor. From 2017 until February 2020, he was CEO of Admeira AG, and from 2020 to July 2021, he served as a member of the Board of Directors at Admeira AG. He was also a member of the Advisory Board of the International Retail Summit (IRS) of the Gottlieb Duttweiler Institute (GDI) (2010 – July 2021).
Qualification: Degree as business administrator lic.rer.pol from the University of Fribourg.
Other main activities: Since August 2021, he has been a delegate of the Board of Directors of the AG Grand Hotels Engadinerkulm Holding. Furthermore, he is a member of the Board of Neoperl AG, Diaqua AG as well as at Zoologischer Garten Basel AG.
![graphic](https://nswow-imageresizer.azurewebsites.net/remote/report.galenica.com/ar23/app/uploads/7408c1cf-b699-4684-8058-fd38fc8a6705.jpeg?width=1500)
Board member since 2022, born in 1962, Swiss citizen
Corporate Governance:
Independent member
Career highlights: From 2009 to 2016, Judith Meier headed Zurzach Care AG (formerly the Reha Clinic Group) as CEO, was a delegate from 2017 and Vice Chairwoman of the Board of Directors of Zurzach Care AG from 2019 to 2023. She is a co-founder of reha at home AG (founding year 2018). From 1989 to 2001, she was a member of the Great Council of the Canton of Aargau.
Qualifications: Executive Master of Health Service Administration (Eastern Switzerland University of Applied Sciences), qualified physiotherapist.
Other main activities: Since 2017, she has been a member of the Board of Directors of the Cantonal Hospital of Graubünden. She is a board member of reha andeer ag. She has been a member of "SCIANA The Health Leaders Network" since 2019 and a member of the Board of Trustees of the Emil-Burkhardt-foundation since 2021 and its vice president as of 2024.
![graphic](https://nswow-imageresizer.azurewebsites.net/remote/report.galenica.com/ar23/app/uploads/4dfdf89c-94a8-4113-8623-31a25c6bf316.jpeg?width=1500)
Board member since 2023, born in 1972, Swiss citizen
Corporate Governance:
Independent member
Career highlights: Solange Peters is a professor at the University of Lausanne and head of the department of medical oncology at CHUV. She began working at CHUV in 2002, where she started out in internal medicine; since 2006 she has worked in oncology. She is one of the world’s leading experts in the field of lung cancer.
Qualifications: Dr. med., University of Lausanne.
Other main activities: Solange Peters has been a member of ESMO (European Society for Medical Oncology) for over 10 years, and ESMO Chairwoman for the past two years. She has also been President of the ICF (International Cancer Foundation) since 2021 and a member of the board of the Swiss Cancer League since 2017.
![graphic](https://nswow-imageresizer.azurewebsites.net/remote/report.galenica.com/ar23/app/uploads/81134091-d319-48d2-a2b3-dff30a8838d5.jpeg?width=1500)
Board member since 2017, born in 1962, Swiss citizen
Corporate Governance:
Independent member
Career highlights: After completing his studies and being admitted to the Swiss Bar, he held various legal and management positions in international chemical and pharmaceutical companies for more than 30 years with a focus on corporate governance, remuneration systems, sustainability, risk management, ethics and compliance, as well as on financial and corporate structures and M&A, e.g. at Roche (1988–1996), Clariant (1998–2010), Petroplus (2012–2013) and Vifor Pharma (2013-2022). His former positions include memberships on the board of several private and (non-Swiss) public listed companies.
Qualification: Attorney-at-law, master and doctorate in law from the University of Basel.
Other main activities: Dr Andreas Walde is a member of the board of scienceindustries and has served on the boards of SwissHoldings and the Society of Swiss Enterprises in Germany.
![graphic](https://nswow-imageresizer.azurewebsites.net/remote/report.galenica.com/ar23/app/uploads/d0adea41-5319-4a15-85d5-dfca22cb3b0b.jpeg?width=1500)
Board member since 2023, born in 1958, Swiss citizen
Corporate Governance:
Independent member
Career highlights: Jörg Zulauf spent 11 years in management positions at the Roche pharmaceutical Company in Switzerland, Korea and Germany, most recently as Head of the Vitamin Services World division (Finance & IT), which has operations worldwide. In 2000, Jörg Zulauf joined Migros-Genossenschafts-Bund Zürich, where he headed the Finance Department as Vice Chairman of the Corporate Executive Committee until 2022 and was a member of the Retail, Finance and Audit committees. Jörg Zulauf has also served as a member of the Board of Directors of Hotelplan, Migrosbank and Globus, as well as Chairman of the Migros Pension Fund.
Qualification: Master of Law and Attorney-at-Law, MBA (UCLA).
Other main activities: Jörg Zulauf is a member of the Board of Directors of Maerki Baumann & Co Ltd. He is also a member of the Board of Directors of Crealogix Holding AG. Since 2023, he has been Chairman of the Board of Directors at SV Group AG.